INTERFERON-BASED CANCER TREATMENT METHOD, AND PHARMACEUTICAL COMBINATION

The present invention relates to the field of biomedicine. Disclosed herein is interferon-based method and pharmaceutical combination for treating cancer. In particular, the present invention relates to an interferon-based method for treating cancer, comprising i) intermittently administering an int...

Full description

Saved in:
Bibliographic Details
Main Authors ZHUANG, Lu, LIN, Chongyang, ZHU, Peijuan, CHU, Hongran, LIAO, Xiaojin, ZHOU, Weidong, WU, Hanzhou, XIA, Qiuju, SUN, Li, XIAO, Qingjiang, XIAO, Xiaoxue
Format Patent
LanguageEnglish
French
German
Published 29.11.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of biomedicine. Disclosed herein is interferon-based method and pharmaceutical combination for treating cancer. In particular, the present invention relates to an interferon-based method for treating cancer, comprising i) intermittently administering an interferon-based therapeutic agent, and ii) administering an additional anticancer agent, preferably, Gemcitabine, to a subject, wherein said additional anti-cancer agent is administered after the first administration of said intermittent administration of an interferon-based therapeutic agent. The present invention also relates to a pharmaceutical combination for use in said method.
Bibliography:Application Number: EP20220742214